Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021

SELL
$75.51 - $84.79 $335,566 - $376,806
-4,444 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $276,127 - $335,099
3,695 Added 493.32%
4,444 $336,000
Q4 2020

Jan 28, 2021

BUY
$72.61 - $90.2 $54,384 - $67,559
749 New
749 $66,000
Q3 2019

Oct 25, 2019

SELL
$67.4 - $85.11 $182,586 - $230,562
-2,709 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$93.92 - $105.72 $42,451 - $47,785
-452 Reduced 14.3%
2,709 $263,000
Q2 2018

Aug 09, 2018

BUY
$76.01 - $99.03 $240,267 - $313,033
3,161 New
3,161 $298,000
Q4 2017

Feb 14, 2018

SELL
$80.76 - $95.13 $175,168 - $206,336
-2,169 Closed
0 $0
Q3 2017

Dec 05, 2017

SELL
$80.6 - $94.95 $333,442 - $392,808
-4,137 Reduced 65.6%
2,169 $202,000
Q2 2017

Sep 12, 2017

BUY
N/A
6,306
6,306 $573,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.